Rapport Therapeutics, Inc.
RAPP
Jodie situation report
Rapport Therapeutics, Inc.'s move is being confirmed by its market group.
No new filing conclusion is available. 14 of 18 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- At least 12 of 18 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as ROIV begins moving with the group.
Invalidation: The live read weakens if participation falls to 6 of 18 members or fewer.
Who this business touches
The relationships behind RAPP
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
NPCEFiling-linked namepartnerMay 7, 2026 ▾
“21 NeuroPace Master Services Agreement and Statement of Work In November 2023, the Company entered into a master services agreement (the “NeuroPace Agreement”) with NeuroPace Inc.”
NPCEFiling-linked namesupplierNov 6, 2025 ▾
“NeuroPace Master Services Agreement and Statement of Work In November 2023, the Company entered into a master services agreement (the “NeuroPace Agreement”) with NeuroPace Inc.”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
RAPP is currently a Participant in the organic co-movement group Biotech Rare Diseases. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.